References
- Benedetti F., Barbini B., Campori E., Fulgosi M. C., Pontiggia A., Colombo C. Sleep phase advance and lithium to sustain the antidepressant effect of total sleep deprivation in bipolar depression: new findings supporting the internal coincidence model?. J. Psychiatr.Res. 2001; 35: 323–329
- Bier E., Reiter L. T. Using Drosophila melanogaster to uncover human disease gene function and potential drug target proteins. Expert. Opin. Ther. Targets 2002; 6: 387–399
- Cadigan K. M., Nusse R. Wnt signaling: a common theme in animal development. Genes Dev. 1997; 11: 3286–3305
- Chen G., Huang L. D., Jiang Y. M., Manji H. K. The mood-stabilizing agent valproate inhibits the activity of Glycogen Synthase Kinase-3β. J. Neurochem. 1999; 72: 1327–1330, [CROSSREF], [CROSSREF]
- Cohen P., Frame S. The renaissance of GSK3. Nat. Rev. Mol. Cell Biol. 2001; 2: 769–776, [CROSSREF], [CROSSREF], [CSA]
- Detera-Wadleigh S. D. Lithium-related genetics of bipolar disorder. Ann. Med. 2001; 33: 272–285
- Fortini M. E., Bonini N. M. Modeling human neurodegenerative diseases in Drosophila: on a wing and a prayer. Trends Genet. 2000; 16: 161–167, [CROSSREF], [CROSSREF], [CSA]
- Goodwin F. K, Jamison K. R. Manic-Depressive Illness. Oxford University Press, New York 1990
- Goodwin F. K, Wirz-Justice A., Wehr T. A. Evidence that the pathophysiology of depression and the mechanism of drug action of anti-depressant drugs both involve alterations in circadian rhythms. Typical and Atypical Anti-Depressants: Clinical Practice, E. Costa, G. Racagni. Raven Press, New York 1982; pp. 1–11
- Gould T. D., Manji H. K. The Wnt signaling pathway in bipolar disorder. Neuroscientist 2002; 8: 497–511, [CSA]
- Hall A. C., Lucas F. R., Salinas P. C. Axonal remodeling and synaptic differentiation in the cerebellum is regulated by WNT-7a signalling. Cell 2000; 100: 525–535, [CROSSREF], [CROSSREF]
- Hall A. C., Brennan A., Goold R. G., Cleverley K., Lucas F. R., Gordon-Weeks P. R., Salinas P. C. Valproate regulates GSK-3-mediated axonal remodeling and synapsin I clustering in developing neurons. Mol. Cell Neurosci. 2002; 20: 257–270, [CROSSREF], [CROSSREF], [CSA]
- Helfrich-Förster C. Differential control of morning and evening components in the activity rhythm of Drosophila melanogaster-sex-specific differences suggest a different quality of activity. J. Biol. Rhythms 2000; 15: 135–154, [CSA]
- Jain S. The biology of mania. The Decade of the Brain, S. Koslow, R. S. Murthy. ADAMHA-NIMHANS, Bangalore 1995
- Johnsson A., Engelmann W., Pflug B., Klemke W. Period lengthening of human circadian rhythms by lithium carbonate, a prophylactic for depressive disorders. Int. J. Chronobiol. 1983; 8: 129–147
- Jope R. S. Anti-bipolar therapy: mechanism of action of lithium. Mol. Psychiatry 1999; 4: 117–128, [CROSSREF], [CROSSREF], [CSA]
- Klein P. S., Melton D. A. A molecular mechanism for the effect of lithium on development. Proc. Nad. Acad. Sci. USA 1996; 93: 8455–8459, [CROSSREF], [CROSSREF], [CSA]
- Klemfuss H. Rhythms and the pharmacology of lithium. Pharmacol. Ther. 1992; 56: 53–78, [CROSSREF], [CROSSREF]
- Kozlovsky N., Belmaker R. H., Agam G. GSK-3 and the neurodevelopmental hypothesis of schizophrenia. Eur. Neuropsychopharmacol. 2002; 12: 13–25, [CROSSREF], [CROSSREF], [CSA]
- Lenox R. H., Gould T. D., Manji H. K. Endophenotypes in bipolar disorder. Am. J. Med. Genet. 2002; 114: 391–406, [CROSSREF], [CROSSREF]
- Li X., Bijur G. N., Jope R.S. Glycogen synthase kinase-3beta, mood stabilizers, and neuroprotection. Bipolar. Disord. 2002; 4: 137–144, [CROSSREF], [CROSSREF], [CSA]
- Lijam N., Paylor R., McDonald M. P., Crawley J. N., Deng C. X., Herrup K, Stevens K. E., Maccaferri G., McBain C. J., Sussman D. J., Wynshaw-Boris A. Social interaction and sensorimotor gating abnormalities in mice lacking. Dvll. Cell 1997; 90: 895–905, [CSA]
- Lucas F. R., Goold R. G., Gordon-Weeks P. R., Salinas P. C. Inhibition of GSK-3beta leading to the loss of phosphorylated MAP-1B is an early event in axonal remodelling induced by WNT-7a or lithium. J. Cell Sci. 1998; 111: 1351–1361
- Lucas F. R., Salinas P. C. WW-7a induces axonal remodeling and increases synapsin I levels in cerebellar neurons. Dev. Biol. 1997; 192: 31–44, [CROSSREF], [CROSSREF]
- Martinek S., Inonog S., Manoukian A. S., Young M. W. A role for the segment polarity gene shaggy/GSK 3 in the Drosophila circadian clock. Cell 2001; 105: 769–779, [CROSSREF], [CROSSREF]
- Moore M. S., DeZazzo J., Luk A. Y., Tully T., Singh C. M., Heberlein U. Ethanol intoxication in Drosophila: genetic and pharmacological evidence for regulation by the cAMP signaling pathway. Cell 1998; 93: 997–1007, [CROSSREF], [CROSSREF]
- Panda S., Hogenesch J. B., Kay S. A. Circadian rhythms from flies to human. Nature 2002; 417: 329–335, [CROSSREF], [CROSSREF]
- Patapoutian A., Reichardt L. F. Roles of Wnt proteins in neural development and maintenance. Curr. Opin. Neurobiol. 2000; 10: 392–399, [CROSSREF], [CROSSREF], [CSA]
- Peifer M., Sweeton D., Casey M., Wieschaus E. Wingless signal and Zeste-white 3 kinase trigger opposing changes in the intracellular distribution of Armadillo. Development 1994; 120: 369–380
- Plyte S. E., Hughes K., Nikolakaki E., Pulverer B. J., Woodgett J. R. Glycogen synthase kinase-3: functions in oncogenesis and development. Biochim. Biophys. Acta. 1992; 1114: 147–162
- Ruel L., Stambolic V., Ali A., Manoukian A. S., Woodgett J. R. Regulation of the protein kinase activity of Shaggy (Zeste-white3) by components of the Wingless pathway in Drosophila cells and embryos. J. Biol. Chem. 1999; 274: 21790–21796, [CROSSREF], [CROSSREF]
- Sharma V. K. A simple computer-aided device for monitoring activity of small mammals and insects. Biol. Rhythm Res. 2003; 34: 3–12, [CROSSREF], [CROSSREF], [CSA]
- Sheeba V., Chandrashekaran M. K., Joshi A., Sharma V. K. Locomotor activity rhythm in Drosophila melanogaster after 600 generations in an aperiodic environment. Naturwissenschaften 2002; 86: 448–449, [CROSSREF], [CROSSREF], [CSA]
- Stambolic V., Ruel L., Woodgett J. R. Lithium inhibits glycogen synthase kinase-3 activity and mimics Wingless signalling in intact cells. Curr. Biol. 1996; 6: 1664–1668, [CROSSREF], [CROSSREF]
- Tickoo S., Russell S. Drosophila melanogaster as a model system for drug discovery and pathway screening. Curr. Opin. Pharmacol. 2002; 2: 555–560, [CROSSREF], [CROSSREF], [CSA]
- Wehr T. A., Wirz-Justice A., Goodwin F. K., Duncan W., Gillin J. C. Phase advance of the circadian sleep-wake cycle as an antidepressant. Science 1979; 206: 710–713
- Williams R. S., Cheng L., Mudge A. W., Harwood A. J. A common mechanism of action for three mood-stabilizing drugs. Nature 2002; 417: 292–295, [CROSSREF], [CROSSREF]
- Williams R. S., Harwood A. J. Lithium therapy and signal transduction. Trends Pharmacol. Sci. 2000; 21: 61–64, [CROSSREF], [CROSSREF]